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Introduction: Left ventricular ejection fraction (LVEF) is a predictor of incident
heart failure (HF). However, baseline LVEF is often unavailable in population
studies of HF.
Material and methods: Of the 5324 Cardiovascular Health Study (CHS)
participants free of baseline HF, 143 (3%) had LVEF < 45% and 1091 (21%)
developed HF during 13 years of follow-up. Using public-use copies of the CHS
data, we compared two predictor models of incident HF, with and without
adjustment for baseline LVEF. 
Results: Baseline impaired LVEF was a strong independent predictor of incident HF
(adjusted hazard ratio, 2.78; P < 0.001) but had no impact on the direction, magnitude
or significance of independent associations of the other predictors of incident HF
such as age, sex, race, coronary artery disease, hypertension and diabetes. 
Conclusion: Baseline LVEF is an important predictor for incident HF but is not
essential in population studies of risk factors for incident HF.
Key words: heart failure, left ventricular ejection fraction, epidemiology, population
studies.
Introduction
Left ventricular (LV) systolic dysfunction (SD) is an important predictor
of incident heart failure (HF) [1]. Therefore, it may be important to collect
and adjust for data on baseline LV ejection fraction (LVEF) in studies of
incident HF. However, cost and other logistical considerations often
preclude collection of baseline data on LVEF in large population studies of
incident HF [2]. The methodological impact of the lack of baseline LVEF
data on the interpretation of the findings from studies of incident HF is
unknown. We used public-use copies of the Cardiovascular Health Study
(CHS) datasets obtained from the National Heart, Lung, and Blood Institute
to compare two multivariable Cox regression models of incident HF with
and without adjustment for baseline LVEF.
Material and methods
The CHS is an ongoing epidemiologic study of cardiovascular disease
in community-dwelling older adults in the United States; the details of the
Corresponding author:
Ali Ahmed MD, MPH
University of Alabama at
Birmingham
1530 3rd Ave South, CH–19,
Ste–219 
Birmingham AL 35294–2041
Phone: +1 205 934 9632
Fax:  +1 205 975 7099
E-mail: aahmed@uab.edu 
Short communication
1University of Alabama at Birmingham, Birmingham, AL, USA 
2Lehigh Valley Hospital, Allentown, Pennsylvania, USA 
3Veterans Affairs Medical Center, Birmingham, AL, USA
Submitted: 25 September 2010 
Accepted: 11 October 2010
Arch Med Sci 2010; 6, 5: 686-688
DOI: 10.5114/aoms.2010.17081
Copyright © 2010 Termedia & BanachArch Med Sci 5, October / 2010 687
rationale, design and implementation of which have
been previously reported [1, 3, 4]. Briefly, an original
cohort of 5201 participants recruited during 1989-
1990, was complemented by a second cohort of
687 African-American participants recruited during
1992-1993. Of 5888 CHS participants, data on 5795
participants were available in the public-use copy
of the dataset (93 participants did not consent to
be included in the de-identified public-use data).
Of the 5324 CHS participants who were free of
baseline HF (centrally adjudicated) and also had
echocardiographic data on baseline LVEF, 143 (2%)
had LVSD, defined as LVEF < 45%. 
Incident HF was centrally adjudicated during
a median follow-up of 12 years. The process 
of adjudication of HF in CHS has been well-
documented in the literature [5-7]. Briefly,
participants were asked about physician-diagnosed
HF during semi-annual visits. The CHS Events
Committee later adjudicated the diagnosis of HF
through the examination of participants’ medical
records for a constellation of symptoms, physical
signs, and other supporting findings suggestive of
HF, use of medications commonly used for HF, and
follow-up surveillance. Two multivariable Cox
regression models were developed to identify
predictors of incident HF. In both models, incident
HF was the dependent variable, and various
demographic, clinical and laboratory variables were
entered as covariates. The models were similar
except that in one model an additional variable for
LVSD was entered as a covariate. 
Resutlts
Participants (n = 5324) had a mean age of 
73 (±6) years, 58% were women and 13% were
African American. Overall, 1091 (21%) participants
developed incident HF during 50,143 person-years
of follow-up. Baseline LVSD had an independent
association with incident HF (adjusted hazard ratio,
2.78; P < 0.001; Table I). Adjustment for LVSD,
however, had no impact on the direction, magnitude
or significance of the independent associations of
other predictors with incident HF. For example,
adjusted hazard ratios for age ≥ 75 years, before
and after LVSD adjustments, were 1.95 and 1.94
respectively (both P < 0.001; Table I). Adjusted
hazard ratios for other predictors of incident HF
were also similar regardless of adjustment for
baseline LVSD (Table I).
Variable Model without LVSD Model with LVSD Absolute 
Adjusted HR P value Adjusted HR P value difference in HR
Age ≥ 75 years 1.95 < 0.001 1.94 < 0.001 0.01
Female gender 0.74 < 0.001 0.76 < 0.001 0.02
African American 0.66 < 0.001 0.67 < 0.001 0.01
Current smoking 1.39 < 0.001 1.42 < 0.001 0.03
General health fair to poor 1.41 < 0.001 1.40 < 0.001 0.01
Coronary artery disease 1.75 < 0.001 1.66 < 0.001 0.09
Hypertension 1.24 0.010 1.27 0.004 0.03
Diabetes mellitus 1.75 < 0.001 1.78 < 0.001 0.03
Stroke 1.30 0.056 1.34 0.033 0.04
Chronic obstructive pulmonary disease 1.23 0.017 1.23 0.017 0.00
Atrial fibrillation 2.44 < 0.001 2.31 < 0.001 0.13
Left ventricular hypertrophy 1.77 < 0.001 1.72 < 0.001 0.05
Systolic blood pressure [mmHg] 1.01 < 0.001 1.01 < 0.001 0.00
Peripheral arterial disease 1.61 < 0.001 1.59 < 0.001 0.02
Serum creatinine [mg/dl] 1.39 < 0.001 1.40 < 0.001 0.01
Serum uric acid [mg/dl] 1.09 < 0.001 1.09 < 0.001 0.00
Serum albumin [g/dl] 0.71 0.002 0.69 0.002 0.02
Serum insulin [µU/ml] 1.003 0.016 1.002 0.024 0.001
C-reactive protein [mg/dl] 1.01 < 0.001 1.01 < 0.001 0.00
Hemoglobin [g/dl] 0.94 0.013 0.94 0.016 0.00
LVSD (ejection fraction < 45%) --- --- 2.78 < 0.001 ---
Table I. Adjusted hazard ratios (HR) for predictors of incident heart failure (HF) in community-dwelling older adults
without prevalent HF, with and without adjustment for baseline left ventricular systolic dysfunction (LVSD)
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Discussion
Findings from this prospective population study
of incident HF demonstrate that the prevalence of
LVSD was low among community-dwelling older
adults without prevalent HF. Although baseline LVSD
was a strong independent predictor of incident HF,
the predictive significance of age, female sex,
African American race, coronary artery disease,
diabetes and others remained unchanged before
and after adjusting for LVSD. Atrial fibrillation was
the only significant predictor of incident HF that
had a > 5% change with additional adjustment of
LVSD; however, it was strongly significant both
before and after adjustment of LVSD. 
Findings of the current analysis suggest that
LVSD had no noticeable impact on the direction,
magnitude or significance of the independent
associations of other predictors of incident HF.
Because LVSD is a very strong predictor of incident
HF, the absence baseline LVSD data may be viewed
as a limitation in population studies of incident HF.
However, findings from our study suggest that in
addition to re-establishing the fact that LVSD is
a strong predictor of incident HF, the costly
collection of baseline LVEF data is unlikely to add
any additional value in studies of other risk factors
of HF. In conclusion, the methodological impact of
the lack of baseline LVEF data on the interpretation
of the findings from studies of incident HF is
negligible, and the lack of baseline LVSD data is not
a major limitation for population studies of
predictors of incident HF.
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